Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

WHO's ICOPE program tested to keep seniors independent

NCT ID NCT06676839

Prevention Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests the WHO's ICOPE program, which includes regular check-ins on mobility, memory, nutrition, vision, hearing, and mood, plus personalized care plans. Researchers will follow 1,000 adults aged 65+ for up to 5 years to see if the program prevents age-related decline better than usual care. The goal is to help people stay independent as they age.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WHO ICOPE program (screening, assessment, personalized care plan, and follow-up)
What this could lead to
If it works, this could provide a proven way to help older people stay independent longer by preventing declines in mobility, memory, and other key functions.
What could go wrong
This is a large but early-stage trial testing a complex program, so results may not show clear benefits or may be hard to apply broadly. The program requires significant effort from participants and healthcare providers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Oct 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participants aged 65 years and older. 2. Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted). 3. Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool. 4. Participants affiliated with a social protection system. Exclusion Criteria: 1. Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1 2. Participants living in a dependent elderly care facility. 3. Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment). 4. Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff. 5. Participants with a life-threatening illness with a prognosis of less than 5 years. 6. Participants unable to provide informed written consent. 7. Participants under legal protection, guardianship, or trusteeship. 8. Participants participating in another interventional research study. 9. Participants in a relationship with a person participating in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ageing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ageing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Angers University hospital

    RECRUITING

    Angers, 49933, France

  • Bigorre Hospital

    RECRUITING

    Tarbes, France, 65000, France

  • CHIC

    RECRUITING

    Castres, France, 81108, France

  • CHU Toulouse

    RECRUITING

    Toulouse, France, 31000, France

  • Limoges university hospital

    RECRUITING

    Limoges, 87042, France

  • Perpignan Hospital

    RECRUITING

    Perpignan, France, 66046, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.